Document Detail


Protective effects of ranitidine in ibuprofen gastroduodenopathy. An endoscopic controlled double blind study
MedLine Citation:
PMID:  7612060     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Protective Effect of Ranitidine in Ibuprofen Gastroduodenopathy/An endoscopically controlled double-blind study in healthy volunteers. In a randomized parallel double-blind study the gastroduodenal effects of 600 mg ibuprofen racemate (CAS 15687-27-1) tid in the presence of 150 mg ranitidine (CAS 66357-35-5, Sostril) bid or placebo was evaluated in 32 healthy volunteers undergoing upper gastrointestinal endoscopy. Drugs were taken during a period of 7 days. Endoscopic controls were performed at entry and repeated after 7 days of treatment. A damaging score was used to asses the lesions. At entry both groups showed comparable mucosal damages. The median values under ibuprofen/placebo were 1 (range 0-1) and under ibuprofen/ranitidine 1 (range 0-2). After 7 days of treatment the median lesions score increased under ibuprofen/placebo to 8 (range 1-20) whereas corresponding values in the ibuprofen/ranitidine group were constant at 1 (range 1-9). The differences between both groups were statistically significant (p < 0.05). Our data underline the protective effect of ranitidine 150 mg bid against ibuprofen both on the stomach as well as on the duodenum.
Authors:
P Müller; E M Koch; B Simon
Publication Detail:
Type:  Clinical Trial; English Abstract; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Arzneimittel-Forschung     Volume:  45     ISSN:  0004-4172     ISO Abbreviation:  Arzneimittelforschung     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-08-14     Completed Date:  1995-08-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372660     Medline TA:  Arzneimittelforschung     Country:  GERMANY    
Other Details:
Languages:  ger     Pagination:  601-3     Citation Subset:  IM    
Affiliation:
Krankenhaus Salem, Heidelberg.
Vernacular Title:
Schutzwirkung von Ranitidin bei Ibuprofen-Gastroduodenopathie. Eine endoskopisch kontrollierte Doppelblindstudie an Probanden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Double-Blind Method
Endoscopy, Gastrointestinal
Humans
Ibuprofen / antagonists & inhibitors*,  toxicity
Male
Peptic Ulcer / chemically induced,  prevention & control*
Ranitidine / therapeutic use*
Chemical
Reg. No./Substance:
15687-27-1/Ibuprofen; 66357-35-5/Ranitidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experimental studies on the influence of surfactants on intestinal absorption of drugs. Cefadroxil a...
Next Document:  Ranitidine and amoxicillin for eradication of Helicobacter pylori in patients with duodenal ulcer